Live Breaking News & Updates on Herapeutics Market

Stay updated with breaking news from Herapeutics market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Parkinson's UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson's drug

Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation and protect brain cells in Parkinson’s. NLRP3 is a protein that plays a role in regulating a number of inflammatory processes that are believed to contribute to the damage to brain cells that underlies Parkinson’s. ....

Arthur Roach , Parkinson Foundation , United Kingdom , Neumora Therapeutics , Virtual Biotech , Virtual Biotech Director , Preclinical Testing ,

Study suggests a common brain network exists between heart rate deceleration and depression

A new study by researchers at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, suggests a common brain network exists between heart rate deceleration and depression. ....

United States , Eva Dijkstra , Shan Siddiqi , Nature Mental Health , Brigham Department Of Psychiatry , Mass General Brigham , Nature Mental , Brain Circuit , Brain Circuit Therapeutics , Heart Rate , Mental Health , Transcranial Magnetic Stimulation ,

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the. ....

Neumora Therapeutics , Neumora Therapeutic , Free Cash Flow ,

Implications for pathophysiology and therapeutics in chronic inflammatory disorder

This article explores the role of citrullination, a post-translational modification process, in the pathogenesis of chronic diseases such as rheumatoid arthritis, cancer, and neurodegenerative disorders ....

United States , San Diego , Maria Osipova , Sonoma Biotherapeutics , Sengenics Corporation , Cancer Research , Sengenics Corporation Llcapr , American College Of Rheumatology , American College Of Rheumatology Convergence , Autoimmune Autoantigen Panel , Sponsored Content , Image Credit , Pan Autoimmune Autoantigen Panel , Soc Open Sci , Exp Med , Clin Invest , Transl Med , Ageing Research Reviews , Citrullinated Vimentin Presented , Mediated Antitumor , Citrullinated Proteins Recognized , Novel Chimeric Antigen Receptor Tregtherapy , Both Synovial Fluid , American College , Rheumatology Convergence , Content Policy ,

Favourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stock

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying. ....

Cadrenal Therapeutics , Insider Transactions , Nsider Ownership , Share Price ,